Determinants of sensitivity to chemotherapeutic agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8673869
SERIAL NO

11793485

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods for determining the level of resistance of a tumor cell to one or more chemotherapeutic agents, comprising measuring the level of expression of a muscle ankyrin repeat protein in the tumor cell. The invention also provides methods for increasing the sensitivity of a tumor cell to one or more chemotherapeutic agents, comprising administering to the cell an effective amount of an antagonist of a muscle ankyrin repeat protein. The invention further provides compositions for use in accordance with methods of the invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
WESTERN SYDNEY LOCAL HEALTH DISTRICTHAWKESBURY ROAD WESTMEAD NEW SOUTH WALES 2145

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
De, Fazio Anna Maroubra, AU 1 0
Guminski, Alexander David New Farm, AU 1 0
Harnett, Paul Robert Hurstville Grove, AU 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 18, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00